ADiTx Therapeutics, Inc. (87) | Uncategorized (11)
Recent Contracts
-
Revenue Sharing Agreement by and among Aditxt, Inc., Cellvera Global Holdings LLC and Cellvera Asia Limited dated as of March 31, 2022
(Filed With SEC on May 16, 2022)
-
First Amendment to Transaction Agreement dated November 30, 2021, by and between the Company and AiPharma Global Holdings LLC
(Filed With SEC on March 31, 2022)
-
Second Amendment to Transaction Agreement dated December 7, 2021, by and between the Company and AiPharma Global Holdings LLC
(Filed With SEC on March 31, 2022)
-
Third Amendment to Transaction Agreement dated December 17, 2021, by and between the Company and AiPharma Global Holdings LLC
(Filed With SEC on March 31, 2022)
-
Fourth Amendment to Transaction Agreement dated December 22,2021, by and between the Company and AiPharma Global Holdings LLC
(Filed With SEC on March 31, 2022)
-
Floating Charge
(Filed With SEC on November 15, 2021)
-
Transaction Agreement, dated as of October 4, 2021 by and between the company and AiPharma Global Holdings LLC
(Filed With SEC on November 15, 2021)
-
Description of Securities Registered Under Section 12 of the Exchange Act
(Filed With SEC on March 25, 2021)
-
Amendment Agreement, dated August 19, 2020
(Filed With SEC on August 20, 2020)
-
Amendment Agreement, dated July 1, 2020, by and between the Company and Loma Linda University
(Filed With SEC on August 13, 2020)
-
Patent Licensing Agreement, dated February 3, 2020
(Filed With SEC on May 14, 2020)